Abstract

Gildan Activewear will report first-quarter 2026 results on April 30, 2026, Pre-Market, with consensus pointing to a sharp top-line rebound and a mixed earnings trajectory as investors weigh volume normalization, pricing, and cost dynamics.

Market Forecast

Consensus for the current quarter indicates revenue of 1.04 billion US dollars, up 46.50% year over year, with EBIT near 147.56 million US dollars, up 11.34% year over year, and adjusted EPS around 0.38, down 33.19% year over year. The company’s core business is expected to benefit from higher volumes and normalizing inventories, though margins may lag the top-line rebound; within the portfolio, management attention is likely to emphasize execution in core product lines and disciplined cost control. The activewear platform remains the operational centerpiece and should set the tone for quarter-on-quarter performance; within the portfolio, hosiery and underwear offer incremental growth optionality through retail and mass channels, with their contribution sized against last quarter’s approximate revenue base.

Last Quarter Review

In the previous quarter, Gildan Activewear generated revenue of 1.08 billion US dollars (up 31.28% year over year), gross profit margin of 32.21%, GAAP net profit attributable to shareholders of 56.11 million US dollars (net profit margin 5.20%), and adjusted EPS of 0.96 (up 15.66% year over year). A key financial highlight was EBIT of 222.90 million US dollars, up 27.30% year over year, underscoring operating leverage as volumes recovered and cost efficiencies supported profitability. In terms of business mix, activewear represented approximately 85.32% of quarterly sales (about 920.18 million US dollars), while hosiery, underwear, and intimates contributed about 14.68% (approximately 158.30 million US dollars), alongside a 31.28% company-level revenue increase year over year that framed broad-based demand normalization across the portfolio.

Current Quarter Outlook

Main business trajectory: Activewear volume normalization and margin calibration

The current-quarter setup revolves around a strong volume rebound in the core activewear franchise. Consensus revenue growth of 46.50% year over year implies that demand and shipments are accelerating against an easier prior-year comparison, likely aided by healthier downstream inventories and steadier order patterns through imprintable and distributor channels. With the last quarter’s mix indicating that activewear contributed roughly 920.18 million US dollars of sales, the degree to which that business sustains throughput and fill rates will be pivotal for achieving the top-line outlook. Margins appear more nuanced than revenue growth suggests. The implied drop in adjusted EPS to 0.38, despite higher sales, indicates that gross margin and/or opex may be absorbing part of the uplift. Factors behind this mix could include normalized pricing after a period of inflation-driven increases, the lagged flow-through of cotton and input-cost dynamics, and potential channel mix effects if high-volume products or accounts are carrying incremental price investments. The last quarter’s gross profit margin of 32.21% sets a benchmark; incremental quarter-on-quarter movement around that level will likely dictate how much of the volume rebound converts into operating income and EPS. Unit economics within core SKUs also bear monitoring. If volume growth skews toward higher-run-rate items designed for speed and breadth, average selling price may compress modestly, though factory utilization and fixed-cost dilution could offset this on a unit-cost basis. Conversely, if product mix shifts to higher-value styles, gross margin could surprise positively even if aggregate volumes remain robust. Investors will watch for commentary on order books, backlog stability, and replenishment cadence to triangulate price/volume contributions. The market’s expectation of EBIT at 147.56 million US dollars, up 11.34% year over year, implies partial margin capture; clarity on freight, labor, and overhead absorption will help bridge the gap between headline growth and bottom-line potential.

Most promising business vector: Hosiery and underwear contribution and channel execution

Hosiery, underwear, and intimates comprised roughly 14.68% of last quarter’s sales, or about 158.30 million US dollars. While smaller in absolute dollars than core activewear, this category can influence blended profitability through different channel economics, retail mechanics, and shelf-space dynamics. The strategic emphasis this quarter is likely on sustaining distribution breadth, managing promotional intensity, and balancing volume growth with margin integrity as the retail calendar progresses. A core point for investors is how this category scales without diluting consolidated margins. If growth leans on distribution wins or new retail placements, short-term price investments or co-op spending could weigh on near-term profitability. On the other hand, if replenishment velocity improves or reorder rates strengthen, contribution margins may firm even as the segment grows. The company’s previous quarter performance suggests cost control is functioning—evidenced by the 27.30% year-over-year increase in EBIT—and that sets a baseline for evaluating whether hosiery and underwear growth adds or subtracts from consolidated returns this quarter. Given the consensus signals for a company-level revenue rebound and a softer EPS comparison, the mix of incremental growth between activewear and hosiery/underwear matters for the earnings bridge. A proportional rise in hosiery and underwear could exert mild pressure on the consolidated gross margin if retail promotions intensify, whereas steady expansion in core activewear can provide scale benefits. Watchpoints include category-level inventory health at key accounts, promotional cadence, and early reorder indications post-quarter end, all of which may influence full-year run-rate expectations.

What may move the stock now: Margins, cost curve, and guidance cadence

The largest swing factor this quarter is the relationship between revenue growth and profit conversion. Consensus implies a robust sales recovery but a year-over-year decline in adjusted EPS, flagging potential drag from gross margin or opex. Investors will be sensitive to any commentary on cotton and other input trajectories, procurement timing, and the degree to which previously locked-in costs are still rolling through cost of goods sold. If gross margin demonstrates resilience near or above the last reported 32.21% despite heavier volumes and normalized pricing, the negative EPS delta could narrow meaningfully. Second, operating expense discipline and productivity gains are under scrutiny. The step down from last quarter’s 222.90 million US dollars of EBIT to an implied 147.56 million US dollars this quarter reflects the usual seasonality and revenue mix differences, but also embeds assumptions about cost absorption. Updates on manufacturing throughput, shift optimization, and logistics efficiency will help investors assess whether EBIT can track closer to revenue growth than consensus suggests. The net profit margin last quarter was 5.20%; any signs of stabilization in the mid-single-digit range this quarter would likely be taken as a constructive signal that cost headwinds are being contained. Finally, the full-year earnings cadence and management’s guidance philosophy will shape the post-print narrative. Recent communications indicate an adjusted EPS range for 2026 of 4.20–4.40, which effectively anchors expectations for the remainder of the year. Reinforcement of that range, alongside color on order visibility and pricing architecture, could outweigh near-term EPS softness and refocus attention on throughput, margin normalization, and cash generation in subsequent quarters. Conversely, a cautious tone on the cost curve or demand elasticity would challenge the re-acceleration thesis embedded in the revenue consensus.

Analyst Opinions

Analyst commentary collected over the past months is decisively bullish, with a clear majority of published views taking a positive stance. Notable updates include Buy or Outperform reiterations accompanied by higher price targets from several well-followed brokers. One global bank reaffirmed a Buy rating with a price target of 110.00 US dollars, pointing to upside from revenue acceleration and operational execution. Another major institution maintained an Outperform rating and raised its target to 79.00 US dollars, reflecting confidence in the earnings trajectory as costs and pricing normalize. Additional positive endorsements include Buy ratings and target increases into the mid-60 to upper-70 US dollar range, reinforcing a constructive institutional stance. The common thread across these notes is the expectation that revenue growth will continue to improve as volumes normalize, with the investment debate shifting to margin capture and the timing of earnings conversion. The spread between the 46.50% year-over-year revenue growth implied for the current quarter and the 33.19% year-over-year decline in adjusted EPS sets a challenging near-term optics hurdle; however, the bullish majority argues that this tension is transient and largely a function of price normalization and cost pass-through timing. In that context, analysts see scope for upside if gross margin performs better than feared, if opex remains disciplined, or if product mix skews more favorably than conservative models assume. The constructive view also leans on recent evidence of operating leverage. Last quarter’s EBIT of 222.90 million US dollars grew 27.30% year over year on a 31.28% revenue increase, suggesting that as volumes rise, fixed-cost absorption can improve and profitability can expand over time. The current-quarter EBIT consensus of 147.56 million US dollars—albeit seasonally lower—still embeds an 11.34% year-over-year gain, indicating underlying progress even as adjusted EPS reflects near-term puts and takes. Several analysts argue that if the company reaffirms its full-year adjusted EPS range of 4.20–4.40 and pairs that with evidence of steady volume demand, investors may look through short-term EPS volatility and focus on the second-half earnings power. From a stock reaction standpoint, the bullish camp highlights three catalysts that could reinforce their case. First, confirmation that activewear volumes are tracking to expectations would validate the 1.04 billion US dollars revenue consensus and fortify confidence in the broader shipment recovery. Second, any indication that gross margin is holding near the last reported 32.21% despite mix and pricing headwinds would likely lead to upward revisions in the earnings bridge. Third, reiteration of the full-year framework and clearer commentary on input-cost timing could remove uncertainty around near-term profitability and set the stage for multiple support. In summary, the ratio of bullish to bearish published views in the recent period skews decisively positive, and the majority opinion focuses on the durability of the revenue recovery and the path to margin normalization. With consensus expecting a 46.50% year-over-year increase in revenue to 1.04 billion US dollars, an 11.34% year-over-year rise in EBIT to 147.56 million US dollars, and adjusted EPS near 0.38, analysts will pay close attention to gross margin behavior, opex intensity, and guidance cadence. Should these elements align with or surpass cautious assumptions, the bullish thesis anticipates that earnings quality and visibility will improve as the year progresses, supporting continued constructive institutional views.